However, this molecular finding does not assist in distinguishing DDLPS from ALT/WDLPS, as both sarcomas exhibit amplification of MDM2 and most often CDK4. While morphological differentiation is crucial in this context, it is often challenging, particularly in the sclerosing and inflammatory subtypes. This evidence concerns the gene MDM2 and sarcoma.